A randomized , double blind , placebo controlled study was conducted from 2003 to 2008.120 diagnosed MDR-TB patients ( both culture positive and negative ) were enrolled and randomized to receive Standard Regimen + individualized homeopathic medicine ( SR+H ) or Standard Regimen + identical placebo ( SR+P ) .